Potential Therapeutic Targets of Quercetin in the Cutaneous Melanoma Model and Its Cellular Regulation Pathways: A Systematic Review

References

• Saginala K, Barsouk A, Aluru JS, Rawla P, Barsouk A. Epidemiology of melanoma. Med Sci. 2021;9(4):63. doi:10.3390/MEDSCI9040063.
   Google Scholar
• Strashilov S, Yordanov A. Aetiology and pathogenesis of cutaneous melanoma: current concepts and advances. Int J Mol Sci. 2021;22(12):6395. doi:10.3390/IJMS22126395.
   PubMed Web of Science ®Google Scholar
• Schadendorf D, Fisher DE, Garbe C, Gershenwald JE, Grob JJ, Halpern A, Herlyn M, Marchetti MA, McArthur G, Ribas A, et al. Melanoma. Nat Rev Dis Primers. 2015;1(1):15003. doi:10.1038/nrdp.2015.3.
   PubMedGoogle Scholar
• Cancer Today. n.d. [accessed 2023 Feb 12]. https://gco.iarc.fr/today/data-sources-methods
   Google Scholar
• Nunes da Silva CF, Pasqual Melo G, Santos Bernardes S, Cecchini AA. Modelos experimentais de melanoma murino in vivo. Biosaúde. 2016;15(2):73–80.
   Google Scholar
• Patton EE, Mueller KL, Adams DJ, Anandasabapathy N, Aplin AE, Bertolotto C, Bosenberg M, Ceol CJ, Burd CE, Chi P, et al. Melanoma models for the next generation of therapies. Cancer Cell. 2021;39(5):610–31. doi:10.1016/J.CCELL.2021.01.011.
   PubMed Web of Science ®Google Scholar
• Guo W, Wang H, Li C. Signal pathways of melanoma and targeted therapy. Signal Transduct Target Ther. 2021;6(1):424. doi:10.1038/s41392-021-00827-6.
   PubMed Web of Science ®Google Scholar
• Dora CL, Silva LF, Mazzarino L, Siqueira JM, Fernandes D, Pacheco LK, Maioral MF, Santos-Silva MC, Baischl AL, Assreuy J, et al. Oral delivery of a high quercetin payload nanosized emulsion: in vitro and in vivo activity against B16-F10 melanoma. J Nanosci Nanotechnol. 2016;16(2):1275–81. doi:10.1166/jnn.2016.11675.
   PubMed Web of Science ®Google Scholar
• Kashyap D, Mittal S, Sak K, Singhal P, Tuli HS. Molecular mechanisms of action of quercetin in cancer: recent advances. Tumour Biol. 2016;37(10):12927–39. doi:10.1007/s13277-016-5184-x.
   PubMedGoogle Scholar
• Sanchez-Gonzalez PD, Lopez-Hernandez FJ, Duenas M, Prieto M, Sanchez-Lopez E, Thomale J, Ruiz-Ortega M, López-Novoa JM, Morales AI. Differential effect of quercetin on cisplatin-induced toxicity in kidney and tumor tissues. Food Chem Toxicol. 2017;107(Pt A):226–36. doi:10.1016/J.FCT.2017.06.047.
   PubMedGoogle Scholar
• Almatroodi SA, Alsahli MA, Almatroudi A, Verma AK, Aloliqi A, Allemailem KS, Khan AA, Rahmani AH. Potential therapeutic targets of quercetin, a plant flavonol, and its role in the therapy of various types of cancer through the modulation of various cell signaling pathways. Molecules. 2021;26(5):1315. doi:10.3390/molecules26051315.
   PubMed Web of Science ®Google Scholar
• Rather RA, Bhagat M. Quercetin as an innovative therapeutic tool for cancer chemoprevention: molecular mechanisms and implications in human health. Cancer Med. 2020;9(24):9181–92. doi:10.1002/CAM4.1411.
   PubMed Web of Science ®Google Scholar
• Touil YS, Fellous A, Scherman D, Chabot GG. Flavonoid-induced morphological modifications of endothelial cells through microtubule stabilization. Nutr Cancer. 2009;61(3):310–21. doi:10.1080/01635580802521346.
   PubMed Web of Science ®Google Scholar
• Kim YJ. Hyperin and quercetin modulate oxidative stress-induced melanogenesis. Biol Pharm Bull. 2012;35(11):2023–7. doi:10.1248/bpb.b12-00592.
   PubMed Web of Science ®Google Scholar
• Peng D, Chen L, Sun Y, Sun L, Yin Q, Deng S, Niu L, Lou F, Wang Z, Xu Z, et al. Melanoma suppression by quercein is correlated with RIG-I and type I interferon signaling. Biomed Pharmacother. 2020;125:109984. doi:10.1016/J.BIOPHA.2020.109984.
   PubMed Web of Science ®Google Scholar
• Soll F, Ternent C, Berry IM, Kumari D, Moore TC. Quercetin inhibits proliferation and induces apoptosis of B16 melanoma cells in vitro. Assay Drug Dev Technol. 2020;18(6):261–8. doi:10.1089/adt.2020.993.
   PubMed Web of Science ®Google Scholar
• Rafiq RA, Quadri A, Nazir LA, Peerzada K, Ganai BA, Tasduq SA. A potent inhibitor of phosphoinositide 3-kinase (PI3K) and mitogen activated protein (MAP) kinase signalling, quercetin (3, 3’, 4’, 5, 7-pentahydroxyflavone) promotes cell death in ultraviolet (UV)-B-irradiated B16F10 melanoma cells. PLoS One. 2015;10(7):e0131253. doi:10.1371/JOURNAL.PONE.0131253.
   PubMed Web of Science ®Google Scholar
• Bashyal P, Jung HY, Pandey RP, Sohng JK. Comparative study on melanin production and collagen expression profile of polyphenols and their glycosides. Indian J Biochem Biophys. 2019;56(2):137–43. doi:10.56042/ijbb.v56i2.27663.
   Web of Science ®Google Scholar
• Yáñez J, Vicente V, Alcaraz M, Castillo J, Benavente-García O, Canteras M, Teruel JAL. Cytotoxicity and antiproliferative activities of several phenolic compounds against three melanocytes cell lines: relationship between structure and activity. Nutr Cancer. 2004;49(2):191–9. doi:10.1207/S15327914NC4902_11.
   PubMed Web of Science ®Google Scholar
• Nitoda T, Isobe T, Kubo I. Effects of phenolic compounds isolated from Rabdosia japonica on B16‐F10 melanoma cells. Phytother Res. 2008;22(7):867–72. doi:10.1002/PTR.2373.
   PubMed Web of Science ®Google Scholar
• Kubo I, Nitoda T, Nihei K-i Effects of quercetin on mushroom tyrosinase and B16-F10 melanoma cells. Molecules. 2007;12(5):1045–56. doi:10.3390/12051045.
   PubMed Web of Science ®Google Scholar
• Rodriguez J, Yáñez J, Vicente V, Alcaraz M, Benavente-García O, Castillo J, Lorente J, Lozano JA. Effects of several flavonoids on the growth of B16F10 and SK-MEL-1 melanoma cell lines: relationship between structure and activity. Melanoma Res. 2002;12(2):99–107. doi:10.1097/00008390-200204000-00001.
   PubMed Web of Science ®Google Scholar
• Martínez C, Yàñez J, Vicente V, Alcaraz M, Benavente-García O, Castillo J, Lorente J, Lozano JA. Effects of several polyhydroxylated flavonoids on the growth of B16F10 melanoma and Melan-a melanocyte cell lines: influence of the sequential oxidation state of the flavonoid skeleton. Melanoma Res. 2003;13(1):3–9. doi:10.1097/00008390-200302000-00002.
   PubMed Web of Science ®Google Scholar
• Pradhan SJ, Mishra R, Sharma P, Kundu GC. Quercetin and sulforaphane in combination suppress the progression of melanoma through the down regulation of matrix metalloproteinase-9. Exp Ther Med. 2010;1(6):915–20. doi:10.3892/ETM.2010.144.
   PubMed Web of Science ®Google Scholar
• Yang YM, Son YO, Lee SA, Jeon YM, Lee JC. Quercetin inhibits α-MSH-stimulated melanogenesis in B16F10 melanoma cells. Phytother Res. 2011;25(8):1166–73. doi:10.1002/ptr.3417.
   PubMed Web of Science ®Google Scholar
• Forni C, Braglia R, Lentini A, Nuccetelli M, Provenzano B, Tabolacci C, Beninati S. Role of transglutaminase 2 in quercetin-induced differentiation of B16-F10 murine melanoma cells. Amino Acids. 2009;36(4):731–8. doi:10.1007/s00726-008-0158-y.
   PubMed Web of Science ®Google Scholar
• Nie JH, Huang JX, Wu QR, Qin XM, Li ZY. Uncovering the anti-proliferation mechanism and bioactive compounds in red kidney bean coat against B16-F10 melanoma cells by metabolomics and network pharmacology analysis. Food Funct. 2019;10(2):912–24. doi:10.1039/c8fo01738g.
   PubMed Web of Science ®Google Scholar
• Iwashita K, Kobori m, Yamaki K, Tsushida T. Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells. Biosci Biotechnol Biochem. 2000;64(9):1813–20. doi:10.1271/bbb.64.1813.
   PubMed Web of Science ®Google Scholar
• Nakashima S, Matsuda H, Oda Y, Nakamura S, Xu F, Yoshikawa M. Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells. Bioorg Med Chem. 2010;18(6):2337–45. doi:10.1016/j.bmc.2010.01.046.
   PubMed Web of Science ®Google Scholar
• Zhang X, Xu Q, Saiki I. Quercetin inhibits the invasion and mobility of murine melanoma B16-BL6 cells through inducing apoptosis via decreasing Bcl-2 expression. Clin Exp Metastasis. 2000;18(5):415–21. doi:10.1023/a:1010960615370.
   PubMed Web of Science ®Google Scholar
• Loizzo MR, Said A, Tundis R, Hawas UW, Rashed K, Menichini F, Frega NG, Menichini F. Antioxidant and antiproliferative activity of Diospyros lotus L. extract and isolated compounds. Plant Foods Hum Nutr. 2009;64(4):264–70. doi:10.1007/s11130-009-0133-0.
   PubMed Web of Science ®Google Scholar
• Said A, Tundis R, Hawas UW, El-Kousy SM, Rashed K, Menichini F, Bonesi M, Huefner A, Loizzo MR, Menichinib F. In vitro antioxidant and antiproliferative activities of flavonoids from Ailanthus excelsa (Roxb.) (Simaroubaceae) leaves. Z Naturforsch C J Biosci. 2010;65(3–4):180–6. doi:10.1515/znc-2010-3-403.
   PubMed Web of Science ®Google Scholar
• Cao H-H, Tse AK-W, Kwan H-Y, Yu H, Cheng C-Y, Su T, Fong W-F, Yu Z-L. Quercetin exerts anti-melanoma activities and inhibits STAT3 signaling. Biochem Pharmacol. 2014;87(3):424–34. doi:10.1016/j.bcp.2013.11.008.
   PubMed Web of Science ®Google Scholar
• Nagata H, Takekoshi S, Takeyama R, Homma T, Yoshiyuki Osamura R. Quercetin enhances melanogenesis by increasing the activity and synthesis of tyrosinase in human melanoma cells and in normal human melanocytes. Pigment Cell Res. 2004;17(1):66–73. doi:10.1046/j.1600-0749.2003.00113.x.
   PubMedGoogle Scholar
• Rosner K, Röpke C, PlesS V, Skovgaard GL. Late type apoptosis and apoptosis free lethal effect of quercetin in human melanoma. Biosci Biotechnol Biochem. 2006;70(9):2169–77. doi:10.1271/bbb.60129.
   PubMed Web of Science ®Google Scholar
• Kim S-H, Yoo E-S, Woo J-S, Han S-H, Lee J-H, Jung S-H, Kim H-J, Jung J-Y. Antitumor and apoptotic effects of quercetin on human melanoma cells involving JNK/P38 MAPK signaling activation. Eur J Pharmacol. 2019;860:172568. doi:10.1016/j.ejphar.2019.172568.
   PubMed Web of Science ®Google Scholar
• Smit NP, Latter AJ, Naish-Byfield S, Westerhof W, Pavel S, Riley PA. Catechol-O-methyltransferase as a target for melanoma destruction? Biochem Pharmacol. 1994;48(4):743–52. doi:10.1016/0006-2952(94)90052-3.
   PubMed Web of Science ®Google Scholar
• Lama G, Angelucci C, Bruzzese N, Iacopino F, Nori SL, D’Atri S, Turriziani M, Bonmassar E, Sica G. Sensitivity of human melanoma cells to oestrogens, tamoxifen and quercetin: is there any relationship with type I and II oestrogen binding site expression? Melanoma Res. 1998;8(4):313–22. doi:10.1097/00008390-199808000-00004.
   PubMed Web of Science ®Google Scholar
• Patel D, Sharma N. Inhibitory effect of quercetin on epithelial to mesenchymal transition in SK-MEL-28 human melanoma cells defined by in vitro analysis on 3D collagen gels. Onco Targets Ther. 2016;9:6445–59. doi:10.2147/ott.s109253.
   PubMed Web of Science ®Google Scholar
• Piantelli M, Maggiano N, Ricci R, Larocca LM, Capelli A, Scambia G, Isola G, Natali PG, Ranelletti FO. Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cells. J Invest Dermatol. 1995;105(2):248–53. doi:10.1111/1523-1747.ep12317599.
   PubMed Web of Science ®Google Scholar
• Vilkickyte G, Raudone L, Petrikaite V. Phenolic fractions from Vaccinium vitis-idaea L. and their antioxidant and anticancer activities assessment. Antioxidants. 2020;9(12):1261. doi:10.3390/antiox9121261.
   Web of Science ®Google Scholar
• Horváthová K, Chalupa I, Šebová L, Tóthová D, Vachálková A. Protective effect of quercetin and luteolin in human melanoma HMB-2 cells. Mutat Res. 2005;565(2):105–12. doi:10.1016/j.mrgentox.2004.08.013.
   PubMed Web of Science ®Google Scholar
• Miyagawa T, Saito H, Minamiya Y, Mitobe K, Takashima S, Takahashi N, Ito A, Imai K, Motoyama S, Ogawa J. Inhibition of Hsp90 and 70 sensitizes melanoma cells to hyperthermia using ferromagnetic particles with a low Curie temperature. Int J Clin Oncol. 2014;19(4):722–30. doi:10.1007/s10147-013-0606-x.
   PubMed Web of Science ®Google Scholar
• Tabor CW, Tabor H. 1,4-Diaminobutane (putrescine), spermidine, and spermine. Annu Rev Biochem. 1976;45(1):285–306. doi:10.1146/annurev.bi.45.070176.001441.
   PubMedGoogle Scholar
• Galati G, O’Brien PJ. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic Biol Med. 2004;37(3):287–303. doi:10.1016/j.freeradbiomed.2004.04.034.
   PubMed Web of Science ®Google Scholar
• Beninati S, Piacentini M. The transglutaminase family: an overview: minireview article. Amino Acids. 2004;26(4):367–72. doi:10.1007/s00726-004-0091-7.
   PubMed Web of Science ®Google Scholar
• Canini A, Pichichero R, Cicconi R, Mattei MA. Chrysin-induced apoptosis is mediated through p38 and Bax activation in B16-F1 and A375 melanoma cells. Int J Oncol. 2011;38(2):473–83. doi:10.3892/ijo.2010.876.
   PubMed Web of Science ®Google Scholar
• Mhaidat NM, Zhang XD, Jiang CC, Hersey P. Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway. Clin Cancer Res. 2007;13(4):1308–14. doi:10.1158/1078-0432.ccr-06-2216.
   PubMed Web of Science ®Google Scholar
• Zhang XM, Huang SP, Xu Q. Quercetin inhibits the invasion of murine melanoma B16-BL6 cells by decreasing pro-MMP-9 via the PKC pathway. Cancer Chemother Pharmacol. 2004;53(1):82–8. doi:10.1007/s00280-003-0702-0.
   PubMed Web of Science ®Google Scholar
• Thangasamy T, Sittadjody S, Mitchell GC, Mendoza EE, Radhakrishnan VM, Limesand KH, Burd R. Quercetin abrogates chemoresistance in melanoma cells by modulating ΔNp73. BMC Cancer. 2010;10(1):282. doi:10.1186/1471-2407-10-282.
   PubMedGoogle Scholar
• Cardile V, Avola R, Graziano AC, Russo A. Moscatilin, a bibenzyl derivative from the orchid Dendrobium loddigesii, induces apoptosis in melanoma cells. Chem Biol Interact. 2020;323:109075. doi:10.1016/j.cbi.2020.109075.
   PubMed Web of Science ®Google Scholar
• Jose J, Rao PG, Jimmy B. Adverse drug reactions to fluoroquinolone antibiotics – analysis of reports received in a tertiary care hospital. Int J Risk Saf Med. 2008;20(3):169–80. doi:10.3233/jrs-2008-0441.
   Google Scholar
• Tanaka T, Huang X, Halicka HD, Zhao H, Traganos F, Albino AP, Dai W, Darzynkiewicz Z. Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents. Cytometry A. 2007;71(9):648–61. doi:10.1002/cyto.a.20426.
   PubMedGoogle Scholar
• Ye R, Goodarzi AA, Kurz EU, Saito S, Higashimoto Y, Lavin MF, Appella E, Anderson CW, Lees-Miller SP. The isoflavonoids genistein and quercetin activate different stress signaling pathways as shown by analysis of site-specific phosphorylation of ATM, p53 and histone H2AX. DNA Repair (Amst). 2004;3(3):235–44. doi:10.1016/j.dnarep.2003.10.014.
   PubMed Web of Science ®Google Scholar
• Pan J, She M, Xu ZX, Sun L, Yeung SC. Farnesyltransferase inhibitors induce DNA damage via reactive oxygen species in human cancer cells. Cancer Res. 2005;65(9):3671–81. doi:10.1158/0008-5472.can-04-2744.
   PubMed Web of Science ®Google Scholar
• Stommel JM, Wahl GM. Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation. Embo J. 2004;23(7):1547–56. doi:10.1038/sj.emboj.7600145.
   PubMed Web of Science ®Google Scholar
• Shieh SY, Ikeda M, Taya Y, Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell. 1997;91(3):325–34. doi:10.1016/s0092-8674(00)80416-x.
   PubMed Web of Science ®Google Scholar
• Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY, Taya Y, Prives C, Abraham RT. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 1999;13(2):152–7. doi:10.1101/gad.13.2.152.
   PubMed Web of Science ®Google Scholar
• Johnston PA, Grandis JR. Stat3 signaling: anticancer strategies and challenges. Mol Interv. 2011;11(1):18–26. doi:10.1124/mi.11.1.4.
   PubMedGoogle Scholar
• Al Zaid Siddiquee K, Turkson J. STAT3 as a target for inducing apoptosis in solid and hematological tumors. Cell Res. 2008;18(2):254–67. doi:10.1038/cr.2008.18.
   PubMed Web of Science ®Google Scholar
• Niu G, Bowman T, Huang M, Shivers S, Reintgen D, Daud A, Chang A, Kraker A, Jove R, Yu H. Roles of activated Src and Stat3 signaling in melanoma tumor cell growth. Oncogene. 2002;21(46):7001–10. doi:10.1038/sj.onc.1205859.
   PubMed Web of Science ®Google Scholar
• Niu G, Heller R, Catlett-Falcone R, Coppola D, Jaroszeski M, Dalton W, Jove R, Yu H. Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. Cancer Res. 1999;15:59(20):5059–63.
   Google Scholar
• Borden EC. Interferons α and β in cancer: therapeutic opportunities from new insights. Nat Rev Drug Discov. 2019;18(3):219–34. doi:10.1038/s41573-018-0011-2.
   PubMed Web of Science ®Google Scholar
• Adler NR, Haydon A, McLean CA, Kelly JW, Mar VJ. Metastatic pathways in patients with cutaneous melanoma. Pigment Cell Melanoma Res. 2017;30(1):13–27. doi:10.1111/pcmr.12544.
   PubMed Web of Science ®Google Scholar
• Tanzer ML. Current concepts of extracellular matrix. J Orthop Sci. 2006;11(3):326–31. doi:10.1007/s00776-006-1012-2.
   PubMed Web of Science ®Google Scholar
• Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871–90. doi:10.1016/j.cell.2009.11.007.
   PubMed Web of Science ®Google Scholar
• Cao H-H, Cheng C-Y, Su T, Fu X-Q, Guo H, Li T, Tse AK-W, Kwan H-Y, Yu H, Yu Z-L. Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion. Mol Cancer. 2015;14(1):103. doi:10.1186/s12943-015-0367-4.
   PubMedGoogle Scholar
• Yamauchi K, Mitsunaga T, Afroze SH, Uddin MN. Structure-activity relationships of methylquercetin on anti-migration and anti-proliferation activity in B16 melanoma cells. Anticancer Res. 2017;37(4):1575–9. doi:10.21873/anticanres.11487.
   PubMed Web of Science ®Google Scholar
• Wojtowicz-Praga SM, Dickson RB, Hawkins MJ. Matrix metalloproteinase inhibitors. Invest New Drugs. 1997;15(1):61–75. doi:10.1023/a:1005722729132.
   PubMed Web of Science ®Google Scholar
• Organ SL, Tsao MS. An overview of the c-MET signaling pathway. Ther Adv Med Oncol. 2011;3(1):S7–S19. doi:10.1177/1758834011422556.
   PubMedGoogle Scholar
• Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol. 2003;4(12):915–25. doi:10.1038/nrm1261.
   PubMed Web of Science ®Google Scholar
• Yang L, Friedland S, Corson N, Xu L. GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2. Cancer Res. 2014;74(4):1022–31. doi:10.1158/0008-5472.can-13-1268.
   PubMed Web of Science ®Google Scholar
• Facchiano F, D’Arcangelo D, Lentini A, Rossi S, Senatore C, Pannellini T, Tabolacci C, Facchiano AM, Facchiano A, Beninati S. Tissue transglutaminase activity protects from cutaneous melanoma metastatic dissemination: an in vivo study. Amino Acids. 2013;44(1):53–61. doi:10.1007/s00726-012-1351-6.
   PubMed Web of Science ®Google Scholar
• Di Giacomo G, Lentini A, Beninati S, Piacentini M, Rodolfo C. In vivo evaluation of type 2 transglutaminase contribution to the metastasis formation in melanoma. Amino Acids. 2009;36(4):717–24. doi:10.1007/s00726-008-0119-5.
   PubMed Web of Science ®Google Scholar
• Xu L, Begum S, Hearn JD, Hynes RO. GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis. Proc Natl Acad Sci U S A. 2006;103(24):9023–8. doi:10.1073/pnas.0602681103.
   PubMed Web of Science ®Google Scholar
• Pizzimenti S, Ribero S, Cucci MA. Oxidative stress-related mechanisms in melanoma and in the acquired resistance to targeted therapies. Antioxidants. 2021;10(12):1942. doi:10.3390/antiox10121942.
   Web of Science ®Google Scholar
• Roh HJ, Noh H-J, Na CS, Kim CS, Kim KH, Hong CY, Lee KR. Phenolic compounds from the leaves of Stewartia pseudocamellia maxim. and their whitening activities. Biomol Ther (Seoul). 2015;23(3):283–9. doi:10.4062/biomolther.2014.140.
   PubMed Web of Science ®Google Scholar
• Chung HT, Pae HO, Choi BM, Billiar TR, Kim YM. Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun. 2001;282(5):1075–9. doi:10.1006/bbrc.2001.4670.
   PubMed Web of Science ®Google Scholar
• Ferrer P, Asensi M, Priego S, Benlloch M, Mena S, Ortega A, Obrador E, Esteve JM, Estrela JM. Nitric oxide mediates natural polyphenol-induced Bcl-2 down-regulation and activation of cell death in metastatic B16 melanoma. J Biol Chem. 2007;282(5):2880–90. doi:10.1074/jbc.m605934200.
   PubMed Web of Science ®Google Scholar
• Awad HM, Boersma MG, Boeren S, van der Woude H, van Zanden J, van Bladeren PJ, Vervoort J, Rietjens IMCM. Identification ofo-quinone/quinone methide metabolites of quercetin in a cellular in vitro system. FEBS Lett. 2002;520(1–3):30–4. doi:10.1016/s0014-5793(02)02754-0.
   PubMed Web of Science ®Google Scholar
• Thangasamy T, Sittadjody S, Lanza-Jacoby S, Wachsberger PR, Limesand KH, Burd R. Quercetin selectively inhibits bioreduction and enhances apoptosis in melanoma cells that overexpress tyrosinase. Nutr Cancer. 2007;59(2):258–68. doi:10.1080/01635580701499545P.
   PubMed Web of Science ®Google Scholar
• Riley PA. Melanogenesis and melanoma. Pigment Cell Res. 2003;16(5):548–52. doi:10.1034/j.1600-0749.2003.00069.x. E.T.
   PubMedGoogle Scholar
• Arung ET, Furuta S, Ishikawa H, Kusuma IW, Shimizu K, Kondo R. Anti-melanogenesis properties of quercetin- and its derivative-rich extract from Allium cepa. Food Chem. 2011;124(3):1024–8. doi:10.1016/j.foodchem.2010.07.067.
   Web of Science ®Google Scholar
• FujiI T, Saito M. Inhibitory effect of quercetin isolated from rose hip (Rosa caninaL.) against melanogenesis by mouse melanoma cells. Biosci Biotechnol Biochem. 2009;73(9):1989–93. doi:10.1271/bbb.90181.
   PubMed Web of Science ®Google Scholar
• Motoyashiki T, Morita T, Ueki H. Involvement of the rapid increase in cAMP content in the vanadate-stimulated release of lipoprotein lipase activity from rat fat pads. Biol Pharm Bull. 1996;19(11):1412–6. doi:10.1248/bpb.19.1412.
   PubMed Web of Science ®Google Scholar
• Busca R, Ballotti R. Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res. 2000;13(2):60–9. doi:10.1034/j.1600-0749.2000.130203.x.
   PubMedGoogle Scholar
• Shibahara S, Takeda K, Yasumoto K, Udono T, Watanabe K, Saito H, Takahashi K. Microphthalmia-associated transcription factor (MITF): multiplicity in structure, function, and regulation. J Investig Dermatol Symp Proc. 2001;6(1):99–104. doi:10.1046/j.0022-202x.2001.00010.x.
   PubMedGoogle Scholar
• Takekoshi S, Nagata H, Kitatani K. Flavonoids enhance melanogenesis in human melanoma cells. Tokai J Exp Clin Med. 2014;39(3):116–21.
   PubMedGoogle Scholar
• Turner KA, Manouchehri JM, Kalafatis M. Sensitization of recombinant human tumor necrosis factor-related apoptosis-inducing ligand-resistant malignant melanomas by quercetin. Melanoma Res. 2018;28(4):277–85. doi:10.1097/cmr.0000000000000447.
   PubMed Web of Science ®Google Scholar
• Kalafatis M, A Turner K, J Lindner D, Kalafatis M. Recombinant human tumor necrosis factor-related apoptosis-inducing ligand selectively induces apoptosis in malignant melanoma. IJCO. 2017;4(1):1–8. doi:10.15436/2377-0902.17.1191.
   Google Scholar
• Brand MD, Nicholls DG. Assessing mitochondrial dysfunction in cells. Biochem J. 2011;435(2):297–312. doi:10.1042/bj20110162.
   PubMed Web of Science ®Google Scholar
• Sturza A, Pavel I, Ancușa S, Danciu C, Dehelean C, Duicu O, Muntean D. Quercetin exerts an inhibitory effect on cellular bioenergetics of the B164A5 murine melanoma cell line. Mol Cell Biochem. 2018;447(1–2):103–9. doi:10.1007/s11010-018-3296-x.
   PubMed Web of Science ®Google Scholar
• Yerlikaya A, Kimball SR, Stanley BA. Phosphorylation of eIF2α in response to 26S proteasome inhibition is mediated by the haem-regulated inhibitor (HRI) kinase. Biochem J. 2008;412(3):579–88. doi:10.1042/bj20080324.
   PubMed Web of Science ®Google Scholar
• Piantelli M, Tatone D, Castrilli G, Savini F, Maggiano N, Larocca LM, Ranelletti FO, Natali PG. Quercetin and tamoxifen sensitize human melanoma cells to hyperthermia. Melanoma Res. 2001;11(5):469–76. doi:10.1097/00008390-200110000-00005.
   PubMed Web of Science ®Google Scholar
• Dornas WCA, Oliveira TTD, Dores RGRD, Santos AFD, Nagem TJ. Flavonoides: potencial terapêutico no estresse oxidativo. Journal of Basic and Applied Pharmaceutical Sciences 2007;28(3):241–9.
   Google Scholar
• Hui C, Qi X, Qianyong Z, Xiaoli P, Jundong Z, Mantian M. Flavonoids, flavonoid subclasses and breast cancer risk: a meta-analysis of epidemiologic studies. PLoS One. 2013;8(1):e54318. doi:10.1371/journal.pone.0054318.
   PubMed Web of Science ®Google Scholar
• Huber LS, Rodriguez-Amaya DB. Flavonóis e flavonas: fontes brasileiras e fatores que influenciam a composição em alimentos. Alimentos e Nutrição Araraquara. 2008;19(1):97–108.
   Google Scholar
• Chen Q, Di L, Zhang Y, Li N. Chemical constituents with cytotoxic and anti-inflammatory activity in Hypericum sampsonii and the antitumor potential under the view of cancer-related inflammation. J Ethnopharmacol. 2020;259:112948. doi:10.1016/j.jep.2020.112948.
   PubMed Web of Science ®Google Scholar
• An SM, Kim HJ, Kim JE, Boo YC. Flavonoids, taxifolin and luteolin attenuate cellular melanogenesis despite increasing tyrosinase protein levels. Phytother Res. 2008;22(9):1200–7. doi:10.1002/ptr.2435.
   PubMed Web of Science ®Google Scholar
• Darsandhari S, Dhakal D, Shrestha B, Lee S, Jung N, Jung HJ, Sohng JK. Biosynthesis of bioactive tamarixetin in recombinant Escherichia coli. Biotechnol Appl Biochem. 2021;68(3):531–7. doi:10.1002/bab.1958.
   PubMed Web of Science ®Google Scholar
• Hundsberger H, Stierschneider A, Sarne V. Concentration-dependent pro- and antitumor activities of quercetin in human melanoma spheroids: comparative analysis of 2D and 3D cell culture models. Molecules. 2021;26(3):717. doi:10.3390/molecules26030717.
   PubMed Web of Science ®Google Scholar
• Drewa G, Woźqak A, Pałgan K, Schachtschabel DO, Grzanka A, Sujkowska R. Influence of quercetin on B16 melanotic melanoma growth in C57BL/6 mice and on activity of some acid hydrolases in melanoma tissue. Neoplasma. 2001;48(1):12–8.
   PubMed Web of Science ®Google Scholar
• Caltagirone S, Ranelletti FO, Rinelli A, Maggiano N, Colasante A, Musiani P, Aiello FB, Piantelli M. Interaction with Type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small-cell lung cancer. Am J Respir Cell Mol Biol. 1997;17(1):51–9. doi:10.1165/ajrcmb.17.1.2728.
   PubMed Web of Science ®Google Scholar
• Menon LG, Kuttan R, Kuttan G. Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett. 1995;95(1–2):221–5. doi:10.1016/0304-3835(95)03887-3.
   PubMed Web of Science ®Google Scholar
• Piantelli M, Rossi C, Iezzi M, La Sorda R, Iacobelli S, Alberti S, Natali PG. Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions. J Cell Physiol. 2006;207(1):23–9. doi:10.1002/jcp.20510.
   PubMed Web of Science ®Google Scholar
• Jain AS, Shah SM, Nagarsenker MS, Nikam Y, Gude RP, Steiniger F, Thamm J, Fahr A. Lipid colloidal carriers for improvement of anticancer activity of orally delivered quercetin: formulation, characterization and establishing in vitro–in vivo advantage. J Biomed Nanotechnol. 2013;9(7):1230–40. doi:10.1166/jbn.2013.1636.
   PubMed Web of Science ®Google Scholar
• Kumar N, Kishan N, Biswas S, Gourishetti K, Kamal M, Chamallamudi MR. Anti-metastatic and anticancer potentials of synthesized chalcones in B16-F10 melanoma cells induced metastatic lung cancer in C57BL/6 mice. Indian J Pharm Educ Res. 2021;55(3s):S742–S750. doi:10.5530/ijper.55.3s.181.
   Google Scholar
• Mendoza L, Carrascal T, De Luca M, Fuentes AM, Salado C, Blanco J, Vidal-Vanaclocha F. Hydrogen peroxide mediates vascular cell adhesion molecule-1 expression from interleukin-18–activated hepatic sinusoidal endothelium: implications for circulating cancer cell arrest in the murine liver. Hepatology. 2001;34(2):298–310. doi:10.1053/jhep.2001.26629.
   PubMed Web of Science ®Google Scholar
• Kale R, Saraf M, Juvekar A, Tayade P. Decreased B16F10 melanoma growth and impaired tumour vascularization in BDF1 mice with quercetin-cyclodextrin binary system. J Pharm Pharmacol. 2006;58(10):1351–8. doi:10.1211/jpp.58.10.0008.
   PubMed Web of Science ®Google Scholar
• Honig A, Rieger L, Kapp M, Krockenberger M, Eck M, Dietl J, Kämmerer U. Increased tartrate-resistant acid phosphatase (TRAP) expression in malignant breast, ovarian and melanoma tissue: an investigational study. BMC Cancer. 2006;6(1):199. doi:10.1186/1471-2407-6-199.
   PubMedGoogle Scholar
• Zhu L, Wada M, Usagawa Y, Yasukochi Y, Yokoyama A, Wada N, Sakamoto M, Maekawa T, Miyazaki R, Yonenaga E, et al. Overexpression of cathepsin D in malignant melanoma. Fukuoka Igaku Zasshi. 2013;104(10):370–5. Oct
   PubMedGoogle Scholar
• Bhattacharyya S, Feferman L, Terai K, Dudek AZ, Tobacman JK. Decline in arylsulfatase B leads to increased invasiveness of melanoma cells. Oncotarget. 2017;8(3):4169–80. 10.18632/oncotarget.13751
   PubMedGoogle Scholar
• Stoyanova N, Spasova M, Manolova N, Rashkov I, Georgieva A, Toshkova R. Antioxidant and antitumor activities of novel quercetin-loaded electrospun cellulose acetate/polyethylene glycol fibrous materials. Antioxidants. 2020;9(3):232. doi:10.3390/antiox9030232.
   Web of Science ®Google Scholar
• Popp R, Schimmer O. Induction of sister-chromatid exchanges (SCE), polyploidy, and micronuclei by plant flavonoids in human lymphocyte cultures. a comparative study of 19 flavonoids. Mutat Res. 1991;246(1):205–13. doi:10.1016/0027-5107(91)90123-6.
   PubMedGoogle Scholar
• Harwood M, Danielewska-Nikiel B, Borzelleca JF, Flamm GW, Williams GM, Lines TC. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol. 2007;45(11):2179–205. doi:10.1016/j.fct.2007.05.015.
   PubMed Web of Science ®Google Scholar
• Ruiz MJ, Fernández M, Estela JM, Asensi MÁ, Mañes J, Picó Y. Short-term oral toxicity of quercetin and pterostibene in Swiss mice. Toxicol Lett. 2006;164:S275–S276. doi:10.1016/j.toxlet.2006.07.232.
   Web of Science ®Google Scholar
• D’Andrea G. Quercetin: a flavonol with multifaceted therapeutic applications? Fitoterapia. 2015;106:256–71. doi:10.1016/j.fitote.2015.09.018.
   PubMed Web of Science ®Google Scholar
• Batiha GE, Beshbishy AM, Ikram M. The pharmacological activity, biochemical properties, and pharmacokinetics of the major natural polyphenolic flavonoid: quercetin. Foods. 2020;9(3):374. doi:10.3390/foods9030374.
   PubMed Web of Science ®Google Scholar
• Pamukcu AM, Yalçiner S, Hatcher JF, Bryan GT. Quercetin, a rat intestinal and bladder carcinogen present in bracken fern (Pteridium aquilinum). Cancer Res. 1980;40(10):3468–72.
   PubMed Web of Science ®Google Scholar
• National Toxicology Program. Toxicology and carcinogenesis studies of quercetin (CAS no. 117-39-5) in F344 rats (feed studies). National Toxicology Program technical report series. U.S Departamento of Health and Human Services 1992; Vol. 409. p. 1–171.
   Google Scholar
• Ferry DR, Smith A, Malkhandi J, Fyfe DW, deTakats PG, Anderson D, Kerr DJ. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clinical Cancer Res. 1996;2(4):659–68.
   PubMed Web of Science ®Google Scholar
• Lu NT, Crespi CM, Liu NM, Vu JQ, Ahmadieh Y, Wu S, Lin S, McClune A, Durazo F, Saab S, et al. A phase I dose escalation study demonstrates quercetin safety and explores potential for bioflavonoid antivirals in patients with chronic hepatitis C. Phytother Res. 2016;30(1):160–8. doi:10.1002/ptr.5518.
   PubMed Web of Science ®Google Scholar
• Xu P, Wang H, Hu H, Ye Y, Dong Y, Li S, Mei D, Guo Z, Wang D, Sun Y, et al. cRGDfK-grafted small-size quercetin micelles for enhancing therapy efficacy of active ingredient from the chinese medicinal herb. Int J Nanomedicine. 2019;14:9173–84. doi:10.2147/IJN.S219578.
   PubMed Web of Science ®Google Scholar
• Chen X, Yin OQ, Zuo Z, Chow MS. Pharmacokinetics and modeling of quercetin and metabolites. Pharm Res. 2005;22(6):892–901. doi:10.1007/s11095-005-4584-1.
   PubMed Web of Science ®Google Scholar
• Justino GC, Santos MR, Canário S, Borges C, Florêncio MH, Mira L. Plasma quercetin metabolites: structure–antioxidant activity relationships. Arch Biochem Biophys. 2004;432(1):109–21. doi:10.1016/j.abb.2004.09.007.
   PubMed Web of Science ®Google Scholar
• Kabir MT, Rahman MH, Akter R. Potential role of curcumin and its nanoformulations to treat various types of cancers. Biomolecules. 2021;11(3):392. doi:10.3390/biom11030392.
   PubMed Web of Science ®Google Scholar
• Corina D, Bojin F, Ambrus R, Muntean D, Soica C, Paunescu V, Cristea M, Pinzaru I, Dehelean C. Physico-chemical and biological evaluation of flavonols: fisetin, quercetin and kaempferol alone and incorporated in beta cyclodextrins. Anticancer Agents Med Chem. 2017;17(4):615–26. doi:10.2174/1871520616666160621105306.
   PubMed Web of Science ®Google Scholar
• Indap MA, Bhosle SC, Tayade PT, Vavia PR. Evaluation of toxicity and antitumour effects of a hydroxypropyl β-cyclodextrin inclusion complex of quercetin. Indian J Pharm Sci. 2002;64(4):349.
   Google Scholar
• Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano. 2009;3(1):16–20. doi:10.1021/nn900002m.
   PubMed Web of Science ®Google Scholar
• Shvidchenko AV, Eidelman ED, Vul’ AY, Kuznetsov NM, Stolyarova DY, Belousov SI, Chvalun SN. Colloids of detonation nanodiamond particles for advanced applications. Adv Colloid Interface Sci. 2019;268:64–81. doi:10.1016/j.cis.2019.03.008.
   PubMed Web of Science ®Google Scholar
• Sapino S, Ugazio E, Gastaldi L, Miletto I, Berlier G, Zonari D, Oliaro-Bosso S. Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies. Eur J Pharm Biopharm. 2015;89:116–25. doi:10.1016/j.ejpb.2014.11.022.
   PubMed Web of Science ®Google Scholar
• Gulla, S, Lomada, D, Araveti, PB, Srivastava, A, Murikinati, MK, Reddy, KR, Reddy, MC, Altalhi, T, Inamuddin. Titanium dioxide nanotubes conjugated with quercetin function as an effective anticancer agent by inducing apoptosis in melanoma cells. J Nanostruct Chem. 2021;11:721–34. doi:10.1007/s40097-021-00396-8 S.
   Web of Science ®Google Scholar
• Sree Latha T, Reddy MC, Muthukonda SV, Srikanth VV, Lomada D. In vitro and in vivo evaluation of anti-cancer activity: shape-dependent properties of TiO 2 nanostructures. Mater Sci Eng C Mater Biol Appl. 2017;78:969–77. doi:10.1016/j.msec.2017.04.011.
   PubMed Web of Science ®Google Scholar
• Gulla S, Reddy VC, Araveti PB, Lomada D, Srivastava A, Reddy MC, Reddy KR. Synthesis of titanium nanotubes conjugated with quercetin and its in-vivo anti-tumor activity against skin cancer. J Mol Struct. 2022;1249:131556. doi:10.1016/j.molstruc.2021.131556.
   Web of Science ®Google Scholar
• Date AA, Nagarsenker MS, Patere S, Dhawan V, Gude RP, Hassan PA, Aswal V, Steiniger F, Thamm J, Fahr A. Lecithin-based novel cationic nanocarriers (leciplex) II: improving therapeutic efficacy of quercetin on oral administration. Mol Pharm. 2011;8(3):716–26. doi:10.1021/mp100305h.
   PubMed Web of Science ®Google Scholar
• Gismondi A, Reina G, Orlanducci S, Mizzoni F, Gay S, Terranova ML, Canini A. Nanodiamonds coupled with plant bioactive metabolites: a nanotech approach for cancer therapy. Biomaterials. 2015;38:22–35. doi:10.1016/j.biomaterials.2014.10.057.
   PubMed Web of Science ®Google Scholar